Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT (clinicaltrials.gov) - Aug 7, 2026 - P2 | N=50 | Recruiting | Sponsor: Baptist Health South Florida | Trial completion date: Oct 2030 ➔ Feb 2031 | Initiation date: Apr 2026 ➔ Jul 2026 | Trial primary completion date: Oct 2029 ➔ Feb 2030
Trial completion date • Trial initiation date • Trial primary completion date • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
|